Efficacy and safety of sitagliptin for the treatment of nonalcoholic fatty liver disease with type 2 diabetes mellitus. - Concepedia

Concepedia

Publication | Closed Access

Efficacy and safety of sitagliptin for the treatment of nonalcoholic fatty liver disease with type 2 diabetes mellitus.

63

Citations

0

References

2014

Year

Takayuki Fukuhara, Hideyuki Hyogo, Hidenori Ochi, Hatsue Fujino, Hiromi Kan, Noriaki Naeshiro, Yohji Honda, Daisuke Miyaki, Tomokazu Kawaoka, Masataka Tsuge,

Abstract

Sitagliptin for the treatment of NAFLD with type2 DM was safe and showed similar antidiabetic effects as reported for type 2 DM, suggesting that tight glycemic control would contribute to the improvement of NAFLD based from the findings of correlation between the changes of HbA1c and transaminases.